← FDA Drug Approvals (Drugs@FDA)

KEPPRA

NDA · New Drug Application · Sponsor: UCB INC · Approved 2006-07-31

Drug application

FDA Application #

NDA021872

Application type

New Drug Application

Brand name

KEPPRA

Generic name

LEVETIRACETAM

Active ingredients

LEVETIRACETAM

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

UCB INC

Manufacturer

UCB, Inc.

First approval

2006-07-31

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown